Lead: A coalition of 19 states and the District of Columbia filed suit on Tuesday against the U.S. Department of Health and Human Services (HHS), Secretary Robert F. Kennedy Jr., and the department’s inspector general, seeking to block a recent HHS declaration that labeled puberty blockers, hormone therapy and related treatments for minors as unsafe and ineffective. The plaintiffs say the declaration, issued last Thursday, unlawfully attempts to change federal health policy without the notice-and-comment process required by statute and could chill access to gender-affirming care for young people. The suit was filed in U.S. District Court in Eugene, Oregon, and was led by New York Attorney General Letitia James. HHS has declined to comment on the litigation.
Key Takeaways
- 19 states plus the District of Columbia sued HHS and Secretary Robert F. Kennedy Jr.; the complaint was filed in U.S. District Court in Eugene, Oregon on Tuesday.
- The HHS declaration, released Thursday, characterized puberty blockers, hormone therapy and surgeries for minors as unsafe and ineffective and warned of exclusion from federal programs such as Medicare and Medicaid.
- The lawsuit argues HHS bypassed the Administrative Procedure Act’s notice-and-comment requirements and asks the court to block enforcement of the declaration.
- HHS based its declaration on a peer-reviewed department report that recommended increased emphasis on behavioral interventions and questioned the World Professional Association for Transgender Health (WPATH) standards.
- Major U.S. medical organizations, including the American Medical Association, have criticized the HHS report as inaccurate; most oppose broad restrictions on gender-affirming care for youth.
- HHS also proposed two rules to limit Medicaid and Medicare funding tied to gender-affirming care for minors; those rules are not final and must undergo notice-and-comment rulemaking.
- At least 27 states have enacted laws restricting or banning gender-affirming care for minors; Medicaid programs in slightly less than half of states currently cover such care.
Background
The dispute stems from a December departmental declaration and a contemporaneous HHS study that questioned prevailing clinical guidelines for treating gender dysphoria in adolescents. HHS concluded the evidence supporting medical interventions for minors is limited and urged a shift toward behavioral therapies, raising alarms among clinicians and advocacy groups who view gender-affirming medical care as evidence-based and lifesaving for many youth. The declaration also signaled potential administrative consequences for providers, warning they could be excluded from federal health programs if they offer these treatments to minors.
This legal clash follows broader federal activity. After taking office in January 2025, President Trump signed an executive order directing federal agencies to reduce support for certain types of gender-affirming care for people under 19. The current litigation is the latest front in a patchwork of state and federal actions: some states have adopted protections for transgender patients, while others, including Tennessee, enacted bans that recently survived a 6–3 Supreme Court decision in U.S. v. Skrmetti. That ruling affirmed a Tennessee statute prohibiting puberty blockers and hormone therapy for transgender adolescents under 18.
Main Event
The complaint—led by New York Attorney General Letitia James and joined by Democratic attorneys general from 18 other states and the District of Columbia—contends HHS’s online declaration effectively coerces providers to halt gender-affirming care without following statutory procedures for policymaking. Plaintiffs say the declaration glosses over methodological weaknesses in the HHS report and overstates risks, while bypassing the Administrative Procedure Act’s requirement that substantive federal policy changes be subject to public notice and comment.
HHS issued the declaration last Thursday alongside two proposed rules aimed at limiting federal Medicaid and Medicare funding for gender-affirming care for minors. Although those proposals must clear a formal rulemaking process before they can take effect, the department’s public posture and the declaration’s language, plaintiffs say, already deter providers. Several major medical centers and practitioners have curtailed pediatric gender-related services in recent months, even in jurisdictions where state law permits such care.
In the lawsuit filed in Eugene, Oregon, the states argue the declaration creates immediate legal and practical harms: clinicians face the threat of exclusion from federal programs, insurers and hospitals confront regulatory uncertainty, and families seeking medically indicated care may encounter constrained options. The complaint asks the court to enjoin enforcement of the declaration while the merits are litigated.
Analysis & Implications
The litigation raises core separation-of-powers and administrative-law questions about how federal agencies change substantive health policy. Under the Administrative Procedure Act, agencies generally must provide public notice and a comment period before adopting rules that create binding legal effects. Plaintiffs assert the declaration is more than guidance because it imposes a de facto penalty—exclusion from federal programs—for providers continuing established treatments.
Practically, even nonbinding federal statements from a major agency like HHS can shift provider behavior. Hospitals and clinicians often weigh the risk of losing Medicare or Medicaid participation heavily; a written departmental declaration that calls specific treatments “unsafe and ineffective” can produce rapid institutional responses, including the scaling back of services. That chilling effect is central to the states’ claim of irreparable harm tied to access and standard-of-care continuity for vulnerable patients.
Politically, the case amplifies tensions between conservative federal policy objectives and states that protect or permit gender-affirming care. If the courts allow HHS’s declaration to stand, federal leverage could prompt new restrictions even in states where legislatures and courts have protected access. Conversely, a judicial injunction would reinforce procedural limits on agency action and might slow federal efforts to curtail care through administrative means.
Comparison & Data
| Metric | Reported Figure |
|---|---|
| States with laws restricting or banning care | At least 27 states |
| Medicaid programs covering gender-affirming care | Slightly less than half of states |
These figures illustrate a fragmented landscape: while numerous states have enacted restrictions, many Medicaid programs still cover gender-affirming services. That patchwork creates differing standards of care across state lines and complicates families’ access when federal policy sends contrary signals.
Reactions & Quotes
The lead plaintiff framed the suit as a defense of medical decision-making and procedural norms. New York Attorney General Letitia James criticized the declaration and urged the judiciary to block its enforcement.
“Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices.”
New York Attorney General Letitia James (statement)
The Supreme Court majority opinion in U.S. v. Skrmetti was cited repeatedly by proponents of state restrictions as validating legislative authority on the issue.
“Our role is not ‘to judge the wisdom, fairness, or logic’ of the law before us, but only to ensure that it does not violate the equal protection guarantee of the Fourteenth Amendment.”
Chief Justice John Roberts (majority opinion, U.S. v. Skrmetti)
Medical societies and practitioners have pushed back on HHS findings, arguing the department’s report mischaracterizes peer-reviewed literature and risks harming patient care. Those organizations emphasize that clinical guidelines generally recommend individualized assessment and informed consent by patients and families in consultation with experienced clinicians.
Unconfirmed
- Whether the HHS declaration will result in immediate exclusions of specific providers from Medicare or Medicaid remains untested; no enforcement actions tied to the declaration had been announced as of the filing.
- The precise number of hospitals that have curtailed pediatric gender-affirming services since the declaration is unclear and varies by state and institutional policy.
- The final text and timing of HHS’s proposed rules are subject to change during the notice-and-comment period, so their eventual scope and legal effect are not yet determined.
Bottom Line
This lawsuit spotlights a key legal fault line: how far a federal department can go, through guidance or declarations, in reshaping health-care standards without formal rulemaking. For families and clinicians, the immediate concern is access—whether existing treatment pathways for transgender youth will be narrowed by administrative pressure even where state law permits care.
In the near term, the procedural claims in the complaint could lead a court to pause the declaration’s effect, preserving provider options while the case proceeds. Long term, the litigation will test administrative-law boundaries and shape how health-policy disputes over gender-affirming care are resolved between federal agencies, state governments and the judiciary.
Sources
- CBS News / Associated Press (news report)
- U.S. Department of Health and Human Services (official departmental site; HHS statements and rulemaking notices)
- New York Attorney General (official press statements and litigation filings)
- Supreme Court of the United States (official opinions, including U.S. v. Skrmetti)